NCT07814040Completed
Play Based Approach Among Autism
Effectiveness of the B.A.S.I.C.S. Framework as a Multimodal Play-Based Intervention for Children With Autism Spectrum Disorder: A Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
This pilot study evaluates the effectiveness of the B.A.S.I.C.S. framework, a multimodal play-based intervention designed for children with autism spectrum disorder (ASD). The framework integrates balance, autonomy, social interaction, cognition, and self-reliance through structured, play-based therapeutic activities. The intervention combines motor, sensory, cognitive, communication, and peer-based activities within a therapeutic setting. Children with ASD aged 6-12 years who met the predefined eligibility criteria participated in the intervention. Participants received 45-minute multimodal play therapy sessions three times per week for six weeks. Activities were individualized and progressively graded according to each child's tolerance and performance. The effectiveness of the intervention was evaluated by comparing pre-intervention and post-intervention scores on the WeeFIM (Functional Independence Measure for Children) and the Paediatric Balance Scale. The primary purpose was to determine whether participation in the B.A.S.I.C.S. framework was associated with improvements in functional independence and balance among children with ASD. This study provides preliminary evidence regarding the potential effectiveness of a structured multimodal play-based approach that integrates motor, sensory, cognitive, and social components to support functional outcomes in children with ASD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 28 Aug 2026
- Start date
- 3 Jan 2026
- Primary completion date
- 30 Jul 2026
- Lead sponsor
- Saveetha University
- Diseases
- Autism
- NCT number
- NCT07814040
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 3 Jan 2026 to the primary completion date, 30 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Neurological disorders
- Severe visual impairment
- Severe hearing impairment
Other
- ASD associated with moderate-to-severe intellectual disability
- Musculoskeletal deformities
Who the study is looking for
- Children diagnosed with Autism Spectrum Disorder (ASD) according to DSM-5 criteria
- Age 6-12 years
- Both genders
- Able to understand simple commands
- Mini-Mental State Examination (MMSE) score \>24
Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Saveetha Medical College and Hospital Coordinator of this site? Confirm its status | Chennai | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.